in this issue
Chemical Week Magazine :: Newsbriefs
DSM, JLL form $2-billion pharma services firm
6:52 AM MST | November 22, 2013
DSM and private equity firm JLL Partners (New York) have agreed to form a global contract development and manufacturing organization for the pharmaceutical industry, with anticipated sales of about $2 billion in 2014. The company will be formed by combining DSM Pharmaceutical Products (Parsippany, NJ), the custom manufacturing and technology business of DSM, with Patheon (Toronto), a portfolio company of JLL. The new company will be 51% owned by JLL and 49% by DSM. The transaction is expected to close in the first half of 2014. DSM will deconsolidate DSM...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee